Recombinant human erythropoietin treatment reverses hepatic iron overload in hemodialysis patients.

Y. Berland,M. Baz,D. Di Stefano,T. Merzouk,J. Bartoli,B. Dussol,M. Kasbarian

DOI: https://doi.org/10.1093/OXFORDJOURNALS.NDT.A092147

Abstract:

What problem does this paper attempt to address?

Synthesis, structure, and biological properties of Cu(II) complexes based on diimine ligands

Shi-Li Tang,De-Jun Li,Feng-Jie Ma,Lu-Lin Zhang,Bo Lian,Yuan-Zheng Cheng,Li-Ping Zhang

DOI: https://doi.org/10.1016/j.molstruc.2022.134229

IF: 3.841

2023-01-15

Journal of Molecular Structure

Abstract:Three copper(II) complexes, [Cu(phen)2Cl](3,5-DNB) (3,5-HDNB) (1), [Cu(phen)(4-NB)2(H2O)] (2), and [Cu(2,2′-bipy)(4-NB)2(H2O)] (3), [phen = 1,10-phenanthroline, 2,2′-bipy = 2,2′-bipyridine, 3,5-DNB = 3,5-dinitrobenzoate anion, 3,5-HDNB = 3,5-dinitrobenzoic acid, 4-NB = 4-nitrobenzoate], have been synthesized and characterized. The interactions between three complexes and HS-DNA/BSA were determined by UV and fluorescence spectra. The results suggest that these copper(II) complexes interact with HS-DNA in an intercalative way and quench the intrinsic fluorescence of BSA via a static mechanism. The fluorescence data also indicated the complexes exhibited good binding propensity to BSA and the binding site available on BSA for the complexes was only one. The antiproliferative activity of the three complexes against several tumor cell lines (MCF-7, HepG-2, A549, and HeLa) was tested by MTT method. Three complexes displayed cytotoxicity against four tumor cells, but complex 3 is less cytotoxic than complexes 1-2. Moreover, the apoptosis was measured by the Annexin-V/PI double staining methods and the results demonstrated that complex 1 and 2 could induce apoptosis in MCF-7 and HeLa cells, respectively.

chemistry, physical
Synthesis, Crystal Structure, DNA-binding Properties, Cytotoxic and Antioxidation Activities of Several Ternary Copper(ii) Complexes with a New Reduced Schiff Base Ligand

Lei Jia,Jie Shi,Zhi-hong Sun,Fei-fei Li,Yuan Wang,Wei-na Wu,Qin Wang

DOI: https://doi.org/10.1016/j.ica.2012.05.014

IF: 3.118

2012-01-01

Inorganica Chimica Acta

Abstract:Three new ternary copper(II) complexes, [Cu2(phen)2(PDIMAla)(H2O)2](ClO4)2·CH3OH (1), [Cu2(dpq)2(PDIMAla)(H2O)2](ClO4)2·CH3OH (2) and [Cu2(dppq)2(PDIMAla)(H2O)2](ClO4)2·CH3OH (3) (phen=1,10-phenanthroline, dpq=dipyrido[3,2:2′,3′-f]quinoxaline, dppz=dipyrido[3,2-a:2′,3′-c]phenazine, H2PDIMAla=N,N′-(p-xylylene)di-alanine acid) have been synthesized and the complex 1 has been structurally characterized by single-crystal X-ray crystallography, spectrometric titrations, ethidium bromide displacement experiments, CD (circular dichroism) spectral analysis and viscosity measurements. The results indicate that the three compounds, especially the complex 3, can strongly bind to calf-thymus DNA (CT–DNA). The intrinsic binding constants Kb of the ternary copper(II) complexes with CT–DNA are 0.38×105, 1.4×105 and 7.8×105 for 1, 2 and 3, respectively. Comparative cytotoxic activities of the copper(II) complexes are also determined by acid phosphatase assay. The results show that the ternary copper(II) complexes have significant cytotoxic activity against the human hepatic (HepG2), human promyelocytic leukemia (HL60) and human prostate (PC3) cell lines. Investigation of antioxidation property show that all the copper(II) complexes have strong scavenging effects for hydroxyl radicals.
1‐Benzyl‐1H‐indazol‐3‐ol Copper(II) Derivatives as Anticancer Agents: In‐vitro Interaction with DNA/BSA, DFT, Molecular Docking and Cytotoxicity on MCF7 Cells

Shivabasayya V Salimath,Madhvesh Pathak

DOI: https://doi.org/10.1002/slct.202304565

2024-02-14

ChemistrySelect

Abstract:The synthesised Complexes were analyzed for in‐vivo DNA and BSA binding studies by UV‐Vis and Fluorescence titrations and Confirmed by Molecular docking. Later, the DFT computational method was adapted to determine the molecular level insights of the Complexes and DPPH assay and MTT assay was carried out to determine the cytotoxic potential of the Cu(II) derivatives. A set of three copper(II) complexes C28H24CuN4O2 [CuL1], C24H22CuN4O [CuL2] and C26H22CuN4O [CuL3] incorporated with ligands 1‐benzyl‐1H‐indazol‐3‐ol, 2,2′‐bipyridyl and 1,10‐phenanthroline have been synthesized, characterized and subjected for biomedical applications. New copper(II) derivatives were characterized by FTIR, EPR and HRMS spectral tools. Cyclic voltammograms were recorded to ascertain redox potential and UV‐Vis and Fluorometer were employed to establish photophysical properties of all the new copper(II) complexes. Further, these derivatives of Cu(II) were subjected for DNA and BSA binding studies by using absorption‐emission spectral methods and viscosity measurements as well as by molecular docking. DFT studies of the above‐mentioned derivatives suggested square planar geometry along with other relevant molecular investigations. Eventually, these new Cu(II) complexes have been tested with DPPH and MTT assay to determine the cytotoxicity against MCF7 cell lines to observe remarkable potency with IC50 values 80.68 μg/ml, 49.40 μg/ml and 45.91 μg/ml, respectively.

chemistry, multidisciplinary
Synthesis, DNA binding and anticancer properties of new Cu(II) and Zn(II) complexes of a Schiff base ligand containing a triphenylphosphonium as a lipophilic cation

Ozge Gungor,Abdulmecit Gul,Seyit Ali Gungor,Sabahattin Comertpay,Muhammet Kose

DOI: https://doi.org/10.1016/j.jphotochem.2023.115453

IF: 5.141

2024-01-02

Journal of Photochemistry and Photobiology A Chemistry

Abstract:A new quinoline-Schiff base ligand (L TPP ) containing the lipophilic triphenylphosphonium cation and its complexes [Cu(L TPP )Cl]Cl and [Zn(L TPP )Cl]Cl were synthesized and characterized. The structures of the ligand and metal complexes were characterized by FTIR, elemental analysis, NMR (for ligand), UV–Vis absorption and fluorescence spectroscopies. DNA binding interactions of the ligand and its metal complexes were investigated by UV–vis absorption and fluorescence spectroscopies as well as viscosity measurements. The DNA binding affinity ( K b ) for the ligand and complexes [Cu(L TPP )Cl]Cl and [Zn(L TPP )Cl]Cl) obtained from absorption spectra were found as 4.33, 4.66 and 6.01 (×10 5 M −1 ), respectively. The ligand and its Cu(II) complex showed similar propensities to interact with DNA, yet the DNA binding affinity of the Zn(II) complex was relatively higher than free ligand and its Cu(II) complex. Docking studies were conducted in order to further investigate the DNA binding interactions. The ligand and its complexes were screened for their cytotoxic properties towards malignant mesothelioma (H2452) and healthy human umbilical vein endothelial (HUVEC) cells. The Cu(II) and Zn(II) complexes that were loaded into the cells (H2452) confirm their intracellular uptake by fluorescence-based cell imaging. Complex [Zn(L TPP )Cl]Cl emitted fluorescent light even after entering the cell suggesting that the compound can be used for cell tracking purposes. In order to find out whether the compounds we synthesized had the potency to enter human cells, we measured the florescent light emission of H2452 cells treated with the products at their IC 50 concentration for 24 h. In vitro antioxidant properties of the ligand and its metal complexes were also studied.

chemistry, physical
New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity

Siffeen Zehra,Mohammad Shavez Khan,Iqbal Ahmad,Farukh Arjmand

DOI: https://doi.org/10.1080/07391102.2018.1467794

2018-05-07

Journal of Biomolecular Structure and Dynamics

Abstract:New tailored Cu(II) & Zn(II) metal-based antitumor drug entities were synthesized from substituted benzothiazole o‒vanillin Schiff base ligands. The complexes were thoroughly characterized by elemental analysis, spectroscopic studies {IR, 1H & 13C NMR, ESI-MS, EPR} and magnetic susceptibility measurements. The structure activity relationship (SAR) studies of benzothiazole Cu(II) & Zn(II) complexes having molecular formulas [C30H22CuN5O7S2], [C30H20Cl2CuN5O7S2], [C30H20CuF2N5O7S2], [C30H22N4O4S2Zn], [C30H20Cl2N4O4S2Zn], and [C30H20F2N5O7S2Zn], with CT‒DNA were performed by employing absorption, emission titrations, and hydrodynamic measurements. The DNA binding affinity was quantified by K b and K sv values which gave higher binding propensity for chloro-substituted Cu(II) [C30H20Cl2CuN5O7S2] complex, suggestive of groove binding mode with subtle partial intercalation. Molecular properties and drug likeness profile were assessed for the ligands and all the Lipinski's rules were found to be obeyed. The antimicrobial potential of ligands and their Cu(II) & Zn(II) complexes were screened against some notably important pathogens viz., E. coli, S. aureus, P. aeruginosa, B. subtilis, and C. albicans. The cytotoxicity of the complexes [C30H20Cl2CuN5O7S2], [C30H20CuF2N5O7S2], [C30H20Cl2N4O4S2Zn], and [C30H20F2N5O7S2Zn] were evaluated against five human cancer cell lines viz., MCF‒7 (breast), MIA‒PA‒CA‒2 (pancreatic), HeLa (cervix) and Hep‒G2 (Hepatoma) and A498 (Kidney) by SRB assay which revealed that chloro-substituted [C30H20Cl2CuN5O7S2] complex, exhibited pronounced specific cytotoxicity with GI50 value of 4.8 μg/ml against HeLa cell line. Molecular docking studies were also performed to explore the binding modes and orientation of the complexes in the DNA helix.
Synthesis, structural and computational study, DNA binding and cytotoxic activity of Cu(II) complexes of 6- and 7-chloro-2-oxo-1,2-dihydroquinoline-3-carbaldehyde-2-furoyl-hydrazones

Thangavel Thirunavukkarasu,Hazel A. Sparkes,Valentina Gandin,Cristina Marzano,Roberta Bertani,Mirto Mozzon,Anna Scettri,Alberto Albinati,Francesco Demartin,Girolamo Casella,Francesco Ferrante,Alfonso Zoleo,Paolo Sgarbossa,Karuppannan Natarajan

DOI: https://doi.org/10.1016/j.ica.2024.122022

IF: 3.118

2024-03-17

Inorganica Chimica Acta

Abstract:Three new coordination complexes of Cu(II) ions made from two hydrazone ligands, 7-chloro-2-oxo-1,2-dihydroquinoline-3-carbaldehyde-2-furoyl-hydrazone (HL1) and 6-chloro-2-oxo-1,2-dihydroquinoline-3-carbaldehyde-2-furoyl-hydrazone (HL2) have been synthesized and fully characterized by spectroscopic techniques. Their crystal and molecular structures revealed distorted square pyramidal mononuclear complexes: [(L1)Cu(H 2 O) 2 ](NO 3 )·3H 2 O, 1 (NO 3 ), [(L2)Cu(H 2 O) 2 ](NO 3 )·2H 2 O·CH 3 OH, 2 (NO 3 ), and [(L2)Cu(NO 3 )(CH 3 OH)]·2CH 3 OH, 3 , comprising the ligand (L1 and L2) in tridentate fashion (ONO) with two water molecules in 1 + and 2 + , and a single methanol molecule and a nitrate ion in 3 in their respective copper coordination spheres. EPR spectra in frozen methanol revealed the occurrence of several species arising from different coordination environments. A detailed DFT investigation on the energetics of solvents exchange (H 2 O, MeOH, and DMSO) and simulation of the EPR parameters showed that the exchange processes occur easily in solution. The value g z indicated the occurrence of a dimeric aggregate for 2 + . The new copper complexes exhibited a noticeable antiproliferative activity with IC 50 values in the micromolar range against HCT-15, H157, BxPC3, PNS-1, and A431 cell lines and they were found to be 3-fold more effective than cisplatin against pancreatic PSN-1 cell lines. Cross-resistance tests on A2780 and LoVo cancer cell lines and the corresponding multidrug or oxaliplatin resistant sublines showed that complexes 1 (NO 3 ) and 2 (NO 3 ) were equally cytotoxic to sensitive and resistant cells, thus overcoming multidrug and oxaliplatin resistance.

chemistry, inorganic & nuclear
Frozen‐and‐thawed allogeneic platelet gels for treating postoperative chronic wounds

P. Perseghin,G. Sciorelli,D. Belotti,Tiziana Speranza,E. Pogliani,O. Ferro,Monica Gianoli,F. Porta,G. Paolini

DOI: https://doi.org/10.1111/j.1537-2995.2005.00570.x

2005-09-01

Transfusion

Abstract:
Synthesis, characterization and comparative biological activity of a novel set of Cu(II) complexes containing azole-based ligand frames

Courtney E Elwell,Emily Stein,Adam Lewis,Stefan Hamaway,Kennedy A Alexis,Joseph M Tanski,Timothy J Barnum,Colleen M Connelly,Laurie A Tyler

DOI: https://doi.org/10.1016/j.jinorgbio.2024.112736

2024-09-19

Abstract:The synthesis and spectroscopic characterization of three complexes containing a substituted 2-(2-pyridyl)benzothiazole (PyBTh) group in the ligand frame are reported along with the comparative biological activity. The ligands have been substituted at the 6-position with either a methoxy (Py(OMe)BTh) or a methyl group (Py(Me)BTh). Reaction of Py(OMe)BTh with either CuCl2 or Cu(NO3)2·2.5 H2O yielded the monomeric [Cu(Py(OMe)BTh))2(NO3)]NO3·1.5 MeOH, (1·1.5 MeOH) complex or the dimeric [Cu(Py(OMe)BTh)Cl2]2 (2), respectively, with the nuclearity of the complex dependent on the starting Cu(II) salt. Reaction between the methyl substituted ligand and Cu(NO3)2·2.5 H2O resulted in the isolation of Cu(Py(Me)BTh)(NO3)2·0.5 THF (3·0.5 THF). Complexes 1-3 were fully characterized. Cyclic voltammetry measurements were performed on all three complexes as well as on [Cu(PyBTh)2(H2O)](BF4)2 (4), a compound previously reported by us which contains the unsubstituted 2-(2-pyridyl)benzothiazole ligand. The biological activity was studied and included concentration dependent DNA binding and cleavage, antibacterial activity, and cancer cell toxicity. All complexes exhibited DNA cleavage activity, however 2 and 4 were found to be the most potent. Mechanistic studies revealed that the nuclease activity is dependent on an oxidative mechanism reliant principally on O2-. Antibacterial studies revealed complex 4 was more potent compared to 1-3. Cancer cell toxicity studies were carried out on HeLa, PC-3, and MCF7 cells with 1-4, Cu(QBTh)(NO3)2(H2O) and Cu(PyBIm)3(BF4)2. The differences in the observed toxicities suggests the importance of the ligand and its substituents in modulating cell death.
Two Novel Copper Complexes of 2,2′-Bipyridine: Evaluation of the DNA Binding and Cytotoxic Activity

Bao-Li Fei,Wen Li,Wu-Shuang Xu,Yang-Guang Li,Jian-Ying Long,Qing-Bo Liu,Kui-Zhan Shao,Zhong-Min Su,Wei-Yin Sun

DOI: https://doi.org/10.1016/j.jphotobiol.2013.04.011

IF: 6.814

2013-01-01

Journal of Photochemistry and Photobiology B Biology

Abstract:Two novel copper-2,2'-bipyridine complexes [Cu(SAL)(2,2'-bipy)ClO4](2) (1) and [Cu(mu(2)-O)(2,2'-bipy)NO3](2) (2) (HSAL = salicylaldehyde) were synthesized and characterized by X-ray single-crystal diffraction, elemental analysis and IR spectra. The interactions of the complexes with salmon sperm DNA were investigated by viscosity analysis, UV, fluorescence and circular dichroism (CD) spectroscopic techniques. Absorption spectral (K-b=3.00 x 10(5) M-1 (1), 3.49 x 10(5) M-1(2)), emission spectral ((K-sv) 3.33 x 10(4) M-1 (1), 3.40 x 10(4) M-1 (2)), and viscosity measurements reveal that 1 and 2 interact with DNA through intercalation. In fluorimetric studies, the enthalpy (Delta H>0) and entropy (Delta S>0) changes of the reactions between the Cu (II) complexes with DNA demonstrate hydrophobic interactions. In addition, CD study indicates the Cu (II) complexes cause a more B-like to a more A-like conformational change upon binding DNA. All the experimental results show that the interaction mode of the two complexes was greatly affected by the coordination environments of Cu (II) centers. Their in vitro cytotoxicity towards five selected tumor cell lines HepG-2, HeLa, NCI-H460, MCF-7 and HL-60 has been evaluated by MIT method, and 2 exhibits higher growth inhibition of the selected cell lines at concentration of 50 mu M, this result is identical with their DNA binding ability order. (C) 2013 Elsevier B.V. All rights reserved.
Synthesis, Crystal Structure, Dna Binding, Antibacterial, and Cytotoxic Activities of Two Chiral Copper(Ii) Complexes

Bao-Li Fei,Wen Li,Wu-Shuang Xu,Jian-Ying Long,Qing-Bo Liu,Wei-Yin Sun,Christopher E. Anson,Annie K. Powell

DOI: https://doi.org/10.1002/ejic.201300685

IF: 2.551

2013-01-01

European Journal of Inorganic Chemistry

Abstract:Two chiral copper-(II) complexes [Cu(L)(2)Cl]Cl (1) and [Cu(L)(2)Br]Br (2) [L = N-[(pyridin-2-ylmethylene)imino]dehydroabietylamine} have been synthesized and fully characterized. The coordination geometry of the Cu-II ions in 1 and 2 can be described as an intermediate between squarepyramidal and trigonal-bipyramidal. DNA binding studies suggest that the complexes interact with salmon-sperm DNA. through intercalation, and 2 exhibits a higher binding affinity. The new complexes were screened for their antibacterial and cytotoxic ability. They have similar cytotoxic activity and they represent the first rosin-derivative-based simple Schiff base complexes with strong anticancer potential.
Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes

Forogh Adhami,Maliheh Safavi,Maryam Ehsani,Sussan K Ardestani,Franziska Emmerling,Farzaneh Simyari

DOI: https://doi.org/10.1039/c3dt52905c

2014-06-07

Abstract:Three N-(pyridine-2-ylcarbamothioyl)benzamide derivatives were synthesized by the reaction of potassium thiocyanate, benzoyl chloride, and 2-amino pyridine derivatives in one pot. The obtained derivatives were oxidized using copper(ii) chloride. During the oxidation, two hydrogen atoms were removed, cyclization of the derivatives occurred, and finally, three new N-(2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2-ylidene)benzamide derivatives were produced. Coordination of these three new derivative ligands to the copper(II) ion resulted in the formation of three new complexes: dichlorobis(N-(2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2-ylidene)benzamide)copper(II), dichlorobis(N-(7-methyl-2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2ylidene)benzamide)copper(II), and dichlorobis(N-(5-methyl-2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2-ylidene)benzamide)copper(II). All the synthesized products were characterized by IR, (1)H NMR, and (13)C NMR spectroscopies. Crystal structures of the obtained N-(pyridine-2-ylcarbamothioyl)benzamide derivatives, N-(2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2-ylidene)benzamide derivatives, and complexes were determined using X-ray single-crystal diffraction; the positions of atoms, bond lengths, bond angles, and dihedral angles were also determined. In all complexes, the coordination of two large monodentate ligands and two chloride anions to the copper(ii) ion resulted in the formation of a stable planar geometry around the central ion. Three N-(pyridine-2-ylcarbamothioyl)benzamide derivatives, three N-(2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2-ylidene)benzamide derivatives, and three complexes were evaluated for their cytotoxicity against five human cancer cell lines (breast cancer cell line MDA-MB-231, neuroblastoma cell line SK-N-MC, prostate adenocarcinoma cell line LNCap, nasopharyngeal epidermoid carcinoma cell line KB, and liver cancer cell line HEPG-2) using an in vitro analysis. The N-(pyridine-2-ylcarbamothioyl)benzamide derivatives showed no cytotoxic activity, whereas the N-(2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2-ylidene)benzamide derivatives and their complexes showed significant cytotoxicity, especially against MDA-MB-231 and LNCap cell lines. The complexes demonstrated smaller IC50 values than N-(2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2-ylidene)benzamide derivatives.
Copper(II) complexes incorporated with 2,2-bipyridyl and 2,2′-(((1E,1′E)-1,4-phenylene-bis(methanylylidene))bis(azanylylidene)) diphenol derivatives: In-vitro interaction with DNA/BSA, DFT, molecular docking and cytotoxicity

Shivabasayya V. Salimath,Madhvesh Pathak

DOI: https://doi.org/10.1016/j.inoche.2024.112226

IF: 3.428

2024-02-01

Inorganic Chemistry Communications

Abstract:Certain metal complexes have created their own benchmark in the category of cytotoxic drugs. Down the line, copper metal complexes are found among the most prominent biologically active agents of high reputation. Considering breast cancer as one of the epicenters in malignant tumors, a series of three new derivatives of copper(II) CuL1, CuL2 and CuL3 have been synthesized and characterized associated with newly developed ligands 2,2′-(((1E,1′E)-1,4-phenylene-bis(methanylylidene))bis(azanylylidene)) diphenol supported by 2,2-bipyridine. All the complexes appeared in tetracoordination with tetrahedral geometry. The complexes were made to bind with ct-DNA through groove binding as established by molecular docking and computational DFT studies carried out for the determination of the HOMO and LUMO interactions and ESP mapping. Further, confirmation of BSA binding with complexes was confirmed by UV and fluorescence spectral studies. All these copper complexes were subjected for DPPH assay to determine the antioxidant properties, cytotoxicity towards the breast adenocarcinoma was retrieved by MTT assay, dual staining and cell cycle analysis against MCF7 cell line. Eventually, new copper derivative CuL2 (IC50 = 30.20 μg/mL) was found to exhibit the highest anticancer activity as compared to CuL1 (IC50 = 41.07 μg/mL) and CuL3 (IC50 = 42.01 μg/mL).

chemistry, inorganic & nuclear
Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Bai-Hua Chen,Qi-Yan Liu,Xue-Yi Le,Liang He,Daihong Cai

DOI: https://doi.org/10.1039/d2dt02985e

IF: 4

2022-10-06

Dalton Transactions

Abstract:Copper complexes are considered as potential candidates for anticancer therapy and medical applications. In this paper, three new Cu(II) complexes, [Cu(IPY)2](ClO4)2·H2O (CuI1), [Cu(IPY)(L-Phe)H2O]ClO4·0.5H2O (CuI2) and [Cu(IPY)(L-Val)H2O]ClO4 (CuI3) (where IPY = 2-(1H-imidazol-2-yl)pyridine, L-Phe = L-phenylalanine, L-Val = L-valine), with good amphipathic properties were synthesized and characterized. The single crystal X-ray diffraction results revealed that CuI1 was four-coordinated, while CuI2 and CuI3 both adopted a five-coordinated tetragonal pyramidal configuration. Multi-spectral methods, viscosity experiment and molecular docking technique showed that three complexes interacted with DNA through insertion. The results of the gel electrophoresis experiments indicated that DNA was oxidatively cleaved by all the complexes in a concentration-dependent manner. Moreover, singlet oxygen (1O2), hydrogen peroxide (H2O2) and superoxide anion radicals (·O2−) were associated with oxidative cleavage of DNA. All the complexes also had good binding affinity with human serum albumin (HSA). The MB degradation assay revealed that all complexes could react with H2O2 to form ·OH through Fenton-like processes. The complexes displayed good antiproliferative activity against the tested human cancer cells in vitro, including cervical carcinoma cells (HeLa), liver cancer cells (HepG2 and BEL-7402) and gastric adenocarcinoma cells (SGC-7901), but showed lower toxicity to normal liver cells (LO2). The anticancer mechanism research revealed that CuI1, CuI2 and CuI3 arrested the cell cycle at S phase, elevated intracellular reactive oxygen species (ROS) levels and induced loss of mitochondrial membrane potential (MMP). The results indicated that these Cu(II) complexes could induce DNA damage and ROS-mediated mitochondrial dysfunction, leading to cancer cell apoptosis. Our work provided a theoretical basis for the design of new low-toxic and highly efficient anticancer Cu(II) complexes by incorporating biological metabolites and aromatic heterocycle ligands.

chemistry, inorganic & nuclear
Interaction with DNA and Different Effect on the Nucleus of Cancer Cells for Copper(ii) Complexes of N-benzyl Di(pyridylmethyl)amine

Qiu-Yun Chen,Hai-Jian Fu,Wei-Hua Zhu,Yan Qi,Zheng-Ping Ma,Kai-Di Zhao,Jing Gao

DOI: https://doi.org/10.1039/c0dt01616k

IF: 4

2011-01-01

Dalton Transactions

Abstract:Three new copper(II) complexes of N-benzyl di(pyridylmethyl)amine (phdpa) were synthesized and characterized by spectroscopic methods. The interaction between CT-DNA and the complexes was studied by UV and fluorescence titration methods. It was found that the complex [(phdpa)Cu(H(2)O)Ac)](Ac), with the non-planar aromatic heterocyclic ring ligand (phdpa), showed good anticancer properties and could cause the fragmentation of the nucleus, although its interaction with CT-DNA was weaker than that of 1,10-phenanthroline (phen) -based copper(II) complexes. The anticancer activities of copper(II) complexes with phdpa and phen based ligands are correlated to their binding constants with DNA, but phen-based copper(II) complexes did not cause the nucleus fragmentation of HeLa cells. [(phdpa)Cu(H(2)O)Ac)](Ac) can noticeably decrease the oxygen content of a culture solution and of HeLa cells, which make it a new nucleus and oxygen related anticancer copper(II) complex. Information obtained here would be helpful in the design of new antitumor complexes in oxidative therapy.
Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Zhen-Fang Zeng,Qiu-Ping Huang,Jie-Hui Cai,Guang-Jin Zheng,Qiu-Chan Huang,Zi-Lu Liu,Zi-Lu Chen,You-Huan Wei

DOI: https://doi.org/10.3390/molecules26134028

IF: 4.6

2021-07-01

Molecules

Abstract:The purpose of this study was to identify new metal-based anticancer drugs; to this end, we synthesized two new copper(II) complexes, namely [Cu(ncba)4(phen)] (1) and [Cu(ncba)4(bpy)] (2), comprised 4-chloro-3-nitrobenzoic acid as the main ligand. The single-crystal XRD approach was employed to determine the copper(II) complex structures. Binding between these complexes and calf thymus DNA (CT-DNA) and human serum albumin (HSA) was explored by electronic absorption, fluorescence spectroscopy, and viscometry. Both complexes intercalatively bound CT-DNA and statically and spontaneously quenched DNA/HSA fluorescence. A CCK-8 assay revealed that complex 1 and complex 2 had substantial antiproliferative influences against human cancer cell lines. Moreover, complex 1 had greater antitumor efficacy than the positive control cisplatin. Flow cytometry assessment of the cell cycle demonstrated that these complexes arrested the HepG2 cell cycle and caused the accumulation of G0/G1-phase cells. The mechanism of cell death was elucidated by flow cytometry-based apoptosis assays. Western blotting revealed that both copper(II) complexes induced apoptosis by regulating the expression of the Bcl-2(Bcl-2, B cell lymphoma 2) protein family.

chemistry, multidisciplinary,biochemistry & molecular biology
Mixed ligand copper(II)-diimine complexes of 2-formylpyridine- N4-phenylthiosemicarbazone: diimine co-ligands tune the in vitro nanomolar cytotoxicity

Radhakrishnan Kartikeyan,Dhanashree Murugan,Tamilarasan Ajaykamal,Manikandan Varadhan,Loganathan Rangasamy,Marappan Velusamy,Mallayan Palaniandavar,Venugopal Rajendiran

DOI: https://doi.org/10.1039/d3dt00213f

2023-07-04

Abstract:Recently, mixed-ligand copper(II) complexes have received much attention in searching for alternative metallodrugs to cisplatin. A series of mixed ligand Cu(II) complexes of the type [Cu(L)(diimine)](ClO4) 1-6, where the HL is 2-formylpyridine-N4-phenylthiosemicarbazone and the diimine is 2,2'-bipyridine (1), 4,4'-dimethyl-2,2'-bipyridine (2), 1,10-phenanthroline (3), 5,6-dimethyl-1,10-phenanathroline (4), 3,4,7,8-tetramethyl-1,10-phenanthroline (5) and dipyrido-[3,2-f:2',3'-h]quinoxaline (6), has been synthesized and their cytotoxicity in HeLa cervical cancer cells examined. In the molecular structures of 2 and 4, as determined by single-crystal X-ray studies, Cu(II) assumes a trigonal bipyramidal distorted square-based pyramidal (TBDSBP) coordination geometry. DFT studies reveal that the axial Cu-N4diimine bond length, interestingly, varies linearly with the experimental CuII/CuI reduction potential as well as the trigonality index τ of the five-coordinate complexes, and that methyl substitution on diimine co-ligands tunes the extent of the Jahn-Teller distortion at the Cu(II). While 4 is involved in strong DNA groove binding with a hydrophobic interaction of methyl substituents, 6 is involved in stronger binding through partial intercalation of dpq with DNA. Complexes 3, 4, 5, and 6 efficiently cleave supercoiled DNA into NC form in ascorbic acid by generating hydroxyl radicals. Interestingly, 4 exhibits higher DNA cleavage in hypoxic than at normoxic conditions. Notably, except for [CuL]+, all the complexes were stable in 0.5% DMSO-RPMI (without phenol red) cell culture medium up to 48 h at 37 °C. Remarkably, all the complexes show time-dependent cytotoxicity at nanomolar concentrations (IC50, 7.0-182 nM) in HeLa cervical cancer cells compared with uncoordinated ligand HL (IC50 > 10 000 nM). Except for 2 and 3, all the complexes exhibit higher cytotoxicity than [CuL]+ at 48 h. 4 shows (57.2 nM) higher cytotoxicity than 1 (181.5 nM) at 24 h incubation; however, notably, 1 demonstrates phenomenal cytotoxicity (7.0 nM) higher than 4 (13.6 nM) at 48 h incubation. The selectivity index (SI) reveals that complexes 1 and 4 are 53.5 and 37.3, respectively, times less toxic to HEK293 normal cells than to cancerous cells. Except for [CuL]+, all the complexes generate ROS to different extents at 24 h, with 1 producing the highest amount, which is consistent with their redox properties. Also, 1 and 4 exhibit, respectively, sub-G1 and G2-M phase cell arrest in the cell cycle. Therefore, complexes 1 and 4 have the potential to emerge as promising anticancer agents.
Effects of Copper Ions on DNA Binding and Cytotoxic Activity of a Chiral Salicylidene Schiff Base

Bao-Li Fei,Wu-Shuang Xu,Hui-Wen Tao,Wen Li,Yu Zhang,Jian-Ying Long,Qing-Bo Liu,Bing Xia,Wei-Yin Sun

DOI: https://doi.org/10.1016/j.jphotobiol.2014.01.018

IF: 6.814

2014-01-01

Journal of Photochemistry and Photobiology B Biology

Abstract:A chiral Schiff base HL N-(5-bromo-salicylaldehyde)dehydroabietylamine (1) and its chiral dinuclear copper complex [Cu2L4]·4DMF (2) have been synthesized and fully characterized. The interactions of 1 and 2 with salmon sperm DNA have been investigated by viscosity measurements, UV, fluorescence and circular dichroism (CD) spectroscopic techniques. Absorption spectral (Kb=3.30 × 10(5)M(-)(1) (1), 6.63 × 10(5)M(-)(1)(2)), emission spectral (Ksv=7.58 × 10(3)M(-)(1) (1), 1.52 × 10(4)M(-)(1) (2)), and viscosity measurements reveal that 1 and 2 interact with DNA through intercalation and 2 exhibits a higher DNA binding ability. In addition, CD study indicates 2 cause a more evident perturbation on the base stacking and helicity of B-DNA upon binding to it. In fluorimetric studies, the enthalpy (ΔH>0) and entropy (ΔS>0) changes of the reactions between the compounds with DNA demonstrate hydrophobic interactions. 1 and 2 were also screened for their cytotoxic ability and 2 demonstrates higher growth inhibition of the selected cancer cells at concentration of 50 μM, this result is identical with their DNA binding ability order. All the experimental results show that the involvement of Cu (II) centers has some interesting effect on DNA binding ability and cytotoxicity of the chiral Schiff base.
Mechanical nociceptive thresholds of dorsal laminae in horses after local anaesthesia of the palmar digital nerves or dorsal branches of the digital nerve.

C. Paz,J. F. Magalhães,H. M. Mendes,S. R. Rocha Júnior,J. Belknap,G. Alves,R. R. Faleiros

DOI: https://doi.org/10.1016/j.tvjl.2016.05.005

IF: 2.75

2016-08-01

The Veterinary Journal

Abstract:
New Cu (II) and Zn (II) metal chelates derived from azo‐Schiff bases: Synthesis, DNA/BSA binding, anticancer activity and molecular docking studies

Sevgi Kahraman,Ozge Gungor,Sultan Erkan,Isik Didem Karagoz,Muhammet Kose,Mukerrem Kurtoglu

DOI: https://doi.org/10.1002/aoc.7646

IF: 3.9

2024-07-20

Applied Organometallic Chemistry

Abstract:Cu (II) and Zn (II) complexes of azo‐Schiff bases for DNA/BSA binding, anticancer properties. In this study, new Cu (II) and Zn (II) chelates (3–6) of 3‐/or 4‐ethyl and azo chromophore groups (NN) containing Schiff base ligands (2‐{(E)‐[(4‐ethylphenyl)imino]methyl}‐4‐[(E)‐phenyldiazenyl]phenol, HL1 (1) and 2‐{(E)‐[(3‐ethylphenyl)imino]methyl}‐4‐[(E)‐phenyldiazenyl]phenol, HL2 (2) were prepared and characterized by the analytical and spectroscopic methods. Crystal structures of chelates 3, 4 and 6 were determined by single‐crystal X‐ray diffraction studies. The ligands behaved as bidentates, coordinating through the nitrogen atom of the azomethine group (CHN) and the oxygen atom of the α‐hydroxyl group (OH). The metal:ligand ratio in the prepared copper (II) and zinc (II) chelates was found to be 1:2 by analytical and spectral analysis. The bands in the infrared spectra of the metal chelates in the region of 522–504 cm−1 and 467–455 cm−1 are attributed to ν(MO) and ν(MN) vibrations, respectively. When the DNA binding activities of the compounds were examined, it was determined that compound 4 had the highest binding constant. Fluorescence and viscosity data showed that the compounds interact with DNA through minor grove binding mode. Furthermore, anticancer properties of the compounds were investigated. Ligand 2 was found to be highly effective against the HepG2 cell with an IC50 of 0.31 μM. In addition, structural analysis, frontier molecular orbitals, molecular electrostatic potential maps, Hirshfeld surface analysis of the synthesized compounds using computational chemistry methods and anticancer activity studies were carried out by molecular docking.

chemistry, inorganic & nuclear, applied
Dna Binding, Oxidative Dna Cleavage, Cytotoxicity, and Apoptosis-Inducing Activity of Copper(Ii) Complexes with 1,4-Tpbd (N,N,N ',N '-Tetrakis(2-yridylmethyl)benzene-1,4-diamine) Ligand

Dong-Dong Li,Jin-Lei Tian,Wen Gu,Xin Liu,Hui-Hui Zeng,Shi-Ping Yan

DOI: https://doi.org/10.1016/j.jinorgbio.2011.03.012

IF: 4.336

2011-01-01

Journal of Inorganic Biochemistry

Abstract:Three new binuclear copper(II) complexes have been synthesized and structurally characterized by X-ray crystallography, [Cu2(1,4-tpbd)(dafo)2(MeOH)2](ClO4)4·2.5H2O (1), [Cu2(1,4-tpbd) (DMSO)2(ClO4)2](OH)2·6H2O (2) and [Cu2(1,4-tpbd)(OAC)2(ClO4)2]·5H2O (3) (1,4-tpbd=N,N,N′,N′-tetrakis(2-pyridylmethyl)benzene-1,4-diamine). Complex 1 to 3 shows similar binuclear structure and each Cu atom adopts five-coordinated square-pyramidal geometry. The interactions of the three complexes with CT-DNA (Calf-thymus DNA) have been investigated by UV absorption, fluorescence spectroscopy, circular dichroism spectroscopy and viscosity. Furthermore, the three complexes display oxidative cleavage of supercoiled DNA in the presence of external agents. Complex 3 shows higher DNA affinity and nuclease activity may be attributed to its cis structural configuration and labile acetate and perchlorate anions. The cleavage mechanisms between the complexes and plasmid DNA are likely to involve singlet oxygen or singlet oxygen-like entity as reactive oxygen species. In addition, in vitro cytotoxicity studies on the Hela cell line show that the IC50 values of complexes 1–3 are 14.75, 13.67 and 16.58μM, respectively. The apoptosis-inducing activity was also assessed by AO/EB (Acridine Orange/Ethidium bromide) staining assay, indicating they have the potential to act as effective metal-based anticancer drugs.

Recombinant human erythropoietin treatment reverses hepatic iron overload in hemodialysis patients.

Synthesis, structure, and biological properties of Cu(II) complexes based on diimine ligands

Synthesis, Crystal Structure, DNA-binding Properties, Cytotoxic and Antioxidation Activities of Several Ternary Copper(ii) Complexes with a New Reduced Schiff Base Ligand

1‐Benzyl‐1H‐indazol‐3‐ol Copper(II) Derivatives as Anticancer Agents: In‐vitro Interaction with DNA/BSA, DFT, Molecular Docking and Cytotoxicity on MCF7 Cells

Synthesis, DNA binding and anticancer properties of new Cu(II) and Zn(II) complexes of a Schiff base ligand containing a triphenylphosphonium as a lipophilic cation

New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity

Synthesis, structural and computational study, DNA binding and cytotoxic activity of Cu(II) complexes of 6- and 7-chloro-2-oxo-1,2-dihydroquinoline-3-carbaldehyde-2-furoyl-hydrazones

Frozen‐and‐thawed allogeneic platelet gels for treating postoperative chronic wounds

Synthesis, characterization and comparative biological activity of a novel set of Cu(II) complexes containing azole-based ligand frames

Two Novel Copper Complexes of 2,2′-Bipyridine: Evaluation of the DNA Binding and Cytotoxic Activity

Synthesis, Crystal Structure, Dna Binding, Antibacterial, and Cytotoxic Activities of Two Chiral Copper(Ii) Complexes

Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes

Copper(II) complexes incorporated with 2,2-bipyridyl and 2,2′-(((1E,1′E)-1,4-phenylene-bis(methanylylidene))bis(azanylylidene)) diphenol derivatives: In-vitro interaction with DNA/BSA, DFT, molecular docking and cytotoxicity

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Interaction with DNA and Different Effect on the Nucleus of Cancer Cells for Copper(ii) Complexes of N-benzyl Di(pyridylmethyl)amine

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Mixed ligand copper(II)-diimine complexes of 2-formylpyridine- N4-phenylthiosemicarbazone: diimine co-ligands tune the in vitro nanomolar cytotoxicity

Effects of Copper Ions on DNA Binding and Cytotoxic Activity of a Chiral Salicylidene Schiff Base

Mechanical nociceptive thresholds of dorsal laminae in horses after local anaesthesia of the palmar digital nerves or dorsal branches of the digital nerve.

New Cu (II) and Zn (II) metal chelates derived from azo‐Schiff bases: Synthesis, DNA/BSA binding, anticancer activity and molecular docking studies

Dna Binding, Oxidative Dna Cleavage, Cytotoxicity, and Apoptosis-Inducing Activity of Copper(Ii) Complexes with 1,4-Tpbd (N,N,N ',N '-Tetrakis(2-yridylmethyl)benzene-1,4-diamine) Ligand